Samyang Biopharm USA, Inc. (“SYBUSA”) was founded in 2018 with the headquarters in One Kendall Square, Cambridge, MA. Playing a vital role as a business hub in the United States, SYBUSA focuses on out-licensing its nucleic acid drug delivery system developed in Samyang Biopharm, a biopharmaceutical... Read more
This company has no teams yet